Accepting sloppy safety studies and giving in to abortion industry demands to loosen restrictions on mifepristone, President Biden’s Food and Drug Administration (FDA) made a crucial decision. In 2023, the FDA fully authorized telehealth prescriptions of abortion pills with no required in-person visits.*
This week, new research from a team led by Dima Mazen Qato of the University of Southern California (Los Angeles) appeared in the Journal of the American Medical Association (JAMA). The message is that this seemingly small change touched off a huge increase in sales of mifepristone, the “abortion pill”.
Read Full Article: https://www.lifenews.com/2026/04/16/joe-bidens-abortion-pill-expansion-is-why-abortions-are-skyrocketing/
